Skip to content

Depression: all studies

Page 541 of 1,034: studies 5,401 to 5,410 of 10,336, newest first. Back to the depression overview

Research

Neurobiological Correlates of Yogic Practices: A Scientific Inquiry into Mental Health Enhancement and Emotional Regulation

International Journal of Latest Technology in Engineering Management & Applied Science October 25, 2025 Jajbir Singh

Abstract: Yoga has transcended its traditional Indian roots to become a global therapeutic practice with measurable neurobiological effects. Emerging neuroscientific research demonstrates that yogic practices that comprising asana (postures), pranayama (breath regulation), and dhyana (meditation) induce structural and functional brain changes associated with improved mental health, emotional...

Mindfulness-induced modulation of resting-state networks functional connectivity in depressed adults: A systematic review

Research Square October 24, 2025 Emilio Durán, Manuel Vázquez-Frutos, Elisa Alcocer et al. preprint

Abstract Objectives: Depression is linked to abnormalities in resting-state networks (RSNs) such as the Default Mode Network (DMN), Salience Network (SN), and Frontoparietal Network (FPN). Mindfulness-based interventions (MBIs) are effective for treating depression, but their impact on functional connectivity (FC) within and between RSNs remains unclear. This systematic review synthesizes...

History and theoretical framework of MBCT

PsyArXiv October 24, 2025 Barry Tse, Melody Jia-Qi Xu preprint

MBCT combines ancient mindfulness practices with the structured approaches of modern CBT, creating an effective intervention for preventing depressive relapse and addressing a wide range of psychological conditions. The authors explore MBCT's development from its Eastern spiritual origins to its validation in Western clinical contexts. They discuss the dual theoretical frameworks underpinning...

Randomised controlled trial of VR-based observation meditation with AI coaching ('Otti') for stress reduction in university students in the United States: study protocol.

BMJ Open October 23, 2025 Jiheun Hong, Christopher R Shelton, Hayoung Oh

Stress is a major health issue in contemporary society, and mindfulness-based approaches reduce stress and anxiety but face practical barriers to consistent practice; this protocol evaluates a Virtual Reality (VR)-based observation meditation programme with an artificial intelligence (AI) coach ('Otti') that delivers real-time empathic, tailored prompts to support present-focused attention and...

DOI: 10.1136/bmjopen-2024-097236 (opens in new tab) Full text (opens in new tab) Mindfulness Randomized controlled trial Stress, physiological Virtual reality

Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development

Progress in Neuro-Psychopharmacology and Biological Psychiatry October 23, 2025 Danielle Bukovsky, Aron Amaev, Jianmeng Song et al.

Psilocybin, a psychedelic prodrug, has gained renewed interest for its potential to treat various psychiatric disorders, including depression, anxiety, and substance use disorders. While promising, concerns remain regarding its safety profile and the management of potential adverse events (AEs). This systematic review aimed to evaluate the incidence, nature, and severity of adverse events and...

Second-generation mindfulness-based interventions (SG-MBIs) for university students: a scoping review

medRxiv October 22, 2025 Matthew A Aldridge, Nanda Cara, Alan Simpson et al. preprint

Abstract Second-generation mindfulness-based interventions (SG-MBIs) extend typical mindfulness-based interventions (MBIs) by grounding them in Buddhist epistemological and pedagogical frameworks and integrating additional Buddhist-derived practices. Systematic reviews show that MBIs can reduce burnout, distress, anxiety, depression and stress among university students—an issue of increasing...

DOI: 10.1101/2025.10.20.25338430 (opens in new tab) Full text (opens in new tab) Buddhism Psychological intervention Relevance law Grey literature +12

Turning the tide: A randomized controlled trial of a brief digital mindfulness intervention to reduce immediate and delayed negative interpretation bias.

Journal of Affective Disorders October 21, 2025

Objective: The current study aimed to explore the effectiveness and mechanisms of mindfulness on alleviating both immediate and delayed negative interpretation biases (NIB). Method: A total of 105 college students (female: 84.62 %, age: 17-23) with high levels of depression were randomly assigned to a mindfulness-writing group, a mindfulness-only group and a waiting list group, and completed...

Single Treatment With MM120 (Lysergide) in Generalized Anxiety Disorder: A Randomized Clinical Trial.

JAMA October 21, 2025 Reid Robison, Robert Barrow, Craig Conant et al. 22 citations

Effective and well-tolerated pharmacotherapies for generalized anxiety disorder (GAD), which is one of the most common psychiatric disorders, are needed. To determine the dose-response relationship of MM120 (lysergide D-tartrate) in adults with moderate to severe GAD. This phase 2b, multicenter, randomized, double-blind, placebo-controlled study enrolled 198 adults aged 18 to 74 years with a...

Psychedelics and time: Exploring altered temporal perception and its implications for consciousness, neuroscience, and therapy

Psychedelics October 21, 2025 Pu Jiang, Ci Lin, Xiaohui Wang

Psychedelics including psilocybin, dimethyltryptamine, and lysergic acid diethylamide are known to disrupt the normal flow of time perception, for example, producing time dilation, compression, and loss of time. These temporal anomalies provide interesting clues about how the brain processes time, what consciousness is, and what produces the sense of self. This opinion article discusses the...

DOI: 10.61373/pp025p.0041 (opens in new tab) Psilocybin Time perception Consciousness Cognition +10

Neuropharmacology of halogenated DMT analogs: psychoplastogenic and antidepressant properties of 5-Br-DMT, a psychedelic derivative with low hallucinogenic potential

Molecular Psychiatry October 21, 2025 Pol Puigseslloses, Núria Nadal‐gratacós, Berta Fumàs et al. 1 citation

Current first-line antidepressants, such as selective serotonin reuptake inhibitors (SSRI), often present a delayed onset of action and fail to effectively treat a large proportion of patients, leaving a gap in the treatment of mood disorders. Psychedelics have recently emerged as promising alternatives due to their ability to produce fast-acting antidepressant effects through neuroplastic...